In 80 adolescents with thalassaemia-induced diabetes uncontrolled on metformin, weekly dulaglutide cut glucose variability (CV 39.45% to 35.05%) over 24 weeks, while it rose on basal-bolus insulin (39.85% to 43.26%); small open-label trial.
RCTn = 80
Adly et al. Dulaglutide vs insulin in adolescents with thalassaemia-induced diabetes: effect on metabolism and atherogenesis (DIADEMA)